Hyperfine (HYPR) Net Income towards Common Stockholders (2021 - 2026)
Hyperfine posted quarterly Net Income towards Common Stockholders of -$8.6 million for Q1 2026, up 8.44% year-on-year from -$8.0 million in Q1 2025, and down 45.86% on a QoQ basis from -$5.9 million in Q4 2025.
Hyperfine (HYPR) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$8.6 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 8.44% year-over-year to -$8.6 million; the trailing twelve-month figure through Mar 2026 stood at -$34.8 million (up 13.68% YoY), and the FY2025 full-year result was -$35.6 million, up 12.64% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$8.6 million, down from -$5.9 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at -$5.9 million in Q4 2025 and bottomed at -$23.8 million in Q1 2022.
- The 5-year median for Net Income towards Common Stockholders is -$10.6 million (2023), against an average of -$11.9 million.
- The widest annual swing landed in 2022, when Net Income towards Common Stockholders tumbled 205.04%; it then surged 54.07% in 2023.
- A 5-year view of Net Income towards Common Stockholders shows it stood at -$13.1 million in 2022, then advanced by 18.19% to -$10.7 million in 2023, then gained by 2.75% to -$10.4 million in 2024, then soared by 43.1% to -$5.9 million in 2025, then sank by 45.86% to -$8.6 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$8.6 million (Q1 2026), -$5.9 million (Q4 2025), and -$11.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Hyperfine | 149.47 Mn | 108.20 Mn | 1.98 Mn | -8.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.62 Mn |
| Dec 31, 2025 | -5.91 Mn |
| Sep 30, 2025 | -11.02 Mn |
| Jun 30, 2025 | -9.23 Mn |
| Mar 31, 2025 | -9.42 Mn |
| Dec 31, 2024 | -10.39 Mn |
| Sep 30, 2024 | -10.33 Mn |
| Jun 30, 2024 | -10.16 Mn |
| Mar 31, 2024 | -9.85 Mn |
| Dec 31, 2023 | -10.68 Mn |
| Sep 30, 2023 | -10.76 Mn |
| Jun 30, 2023 | -10.64 Mn |
| Mar 31, 2023 | -12.16 Mn |
| Dec 31, 2022 | -13.06 Mn |
| Sep 30, 2022 | -13.17 Mn |
| Jun 30, 2022 | -23.16 Mn |
| Mar 31, 2022 | -23.78 Mn |
| Dec 31, 2021 | -26.09 Mn |
| Sep 30, 2021 | -16.39 Mn |
| Jun 30, 2021 | -14.58 Mn |
| Mar 31, 2021 | -7.79 Mn |